4.6 Review

Combinatorial Nanoparticles for Cancer Diagnosis and Therapy

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 19, Issue 22, Pages 3714-3721

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986712801661176

Keywords

Nanotechnology; cancer therapy; imaging; inorganic nanoparticles; polymeric nanoparticles; liposomes

Funding

  1. Department of Defense Breast Cancer Research Program [BC075097]
  2. Susan G. Komen Postdoctoral Fellowship [KG101213]

Ask authors/readers for more resources

Nanotechnology when engineered together with biotechnology opens a fascinating field with applications in diverse areas such as drug targeting and delivery, medical imaging, biosensing, biomaterials and nanotechnology. Conjugating nanoparticles with biomolecules like QD-herceptin conjugates or QD-aptamer (Apt)-DOX conjugates provides many opportunities for improving many of the current challenges in cancer diagnosis and therapy. This paper reviews combinatorial nanoparticles designed and formulated for cancer imaging and therapy, including inorganic nanoparticles (quantum dots, iron oxide particles, gold nanoparticles and silica and carbon nanoparticles), polymeric nanoparticles (PLGA, PLGA-PEG, PAMAM), liposomes and lipid nanoparticles. These nanoparticles are multifunctional in nature and combine two or more functions like targeting, imaging and therapy. In this review, we have classified these combinatorial targeted nanoparticles into inorganic, polymeric and liposome based nanosystems.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available